Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by APOM is an apolipoprotein and member of the lipocalin protein family. Additionally we are shipping Apolipoprotein M Kits (40) and Apolipoprotein M Proteins (28) and many more products for this protein.
Showing 10 out of 146 products:
Human Monoclonal Apolipoprotein M Primary Antibody for ELISA, WB - ABIN394552
Bailey, Xie, Do, Montpetit, Diaz, Mohan, Keavney, Yusuf, Gerstein, Engert, Anand: Variation at the NFATC2 locus increases the risk of thiazolidinedione-induced edema in the Diabetes REduction Assessment with ramipril and rosiglitazone Medication (DREAM) study. in Diabetes Care 2010
Show all 5 references for ABIN394552
Human Monoclonal Apolipoprotein M Primary Antibody for WB - ABIN395065
Ruaño, Thompson, Kane, Pullinger, Windemuth, Seip, Kocherla, Holford, Wu: Physiogenomic analysis of statin-treated patients: domain-specific counter effects within the ACACB gene on low-density lipoprotein cholesterol? in Pharmacogenomics 2010
Show all 5 references for ABIN395065
Human Monoclonal Apolipoprotein M Primary Antibody for IF, WB - ABIN1105422
Xu, Dahlbäck: A novel human apolipoprotein (apoM). in The Journal of biological chemistry 1999
Show all 4 references for ABIN1105422
Human Monoclonal Apolipoprotein M Primary Antibody for ICC, ELISA - ABIN1724662
Xu, Nilsson-Ehle, Ahrén: Correlation of apolipoprotein M with leptin and cholesterol in normal and obese subjects. in The Journal of nutritional biochemistry 2004
Show all 3 references for ABIN1724662
Human Polyclonal Apolipoprotein M Primary Antibody for EIA, WB - ABIN375171
Karlsson, Lindqvist, Tagesson, Lindahl: Characterization of apolipoprotein M isoforms in low-density lipoprotein. in Journal of proteome research 2006
ApoM is excreted in the urine of children after cardiac surgery in children with acute kidney injury
Hyperglycemia-induced downregulation of apolipoprotein M expression is not via the hexosamine pathway.
ApoM is highly expressed in renal proximal tubule cells and is usually reabsorbed by giantin (show GOLGB1 Antibodies)-associated proteins in a process, which is also affected in kidney disease.
our findings present supportive evidence that ApoM is a regulator of human LRH-1 (show NR5A2 Antibodies) transcription, and further reveal the importance of ApoM as a critical regulator of bile acids metabolism
-724 I/D polymorphism decreases the apoM promoter activity, down-regulates the apoM protein expression level, and increases the risk of myocardial infarction
these findings demonstrated that apoM suppressed TNF-alpha (show TNF Antibodies)-induced expression of ICAM-1 (show ICAM1 Antibodies) and VCAM-1 (show VCAM1 Antibodies) through inhibiting the activity of NF-kappaB (show NFKB1 Antibodies).
role of apoM in lipid metabolism and cardiometabolic diseases.(48-55)
ApoM levels differ according to country of birth and are associated with IR and T2DM only in native-born Swedes, not Iraqis living in Sweden.
Binary logistic regression analysis suggested that both apoM and apoAI mRNA may considered as independent risk factors for fetal macrosomia
ApoM overexpression may have a potential role in improving insulin (show INS Antibodies) resistance in vivo and modulating apoM expression might be a future therapeutic strategy against insulin (show INS Antibodies) resistance in type 2 diabetes.
apoM might facilitate the maintenance of CD4 (show CD4 Antibodies)(+) T-lymphocytes or could modify the T-lymphocytes subgroups in murine spleen
Upon immune stimulation, Apom(-/-) mice developed more severe experimental autoimmune encephalomyelitis, characterized by increased lymphocytes in the central nervous system and breakdown of the blood-brain barrier
LDL receptor (show LDLR Antibodies) and ApoE (show APOE Antibodies) have roles in the clearance of ApoM-associated sphingosine 1-phosphate
ApoM augmented insulin (show INS Antibodies) secretion by maintaining the S1P (show S1PR1 Antibodies) concentration under both in vivo and in vitro conditions.
The present data indicate that the plasma apo-M levels modulate the ability of plasma to mobilize cellular cholesterol, whereas apo-M has no major effect on the excretion of cholesterol into feces.
ApoM can bind oxidized phospholipids, increasing the antioxidant effect of HDL (show HSD11B1 Antibodies).
Results show that apoM, by delivering S1P (show S1PR1 Antibodies) to the S1P (show S1PR1 Antibodies)(1) receptor on endothelial cells, is a vasculoprotective constituent of HDL (show APOA5 Antibodies).
After refolding from inclusion bodies, the crystal structure of apoM (reported here at 2.5 A resolution) displays a novel yet unprecedented seven-stranded beta-barrel structure.
apoM mainly associates with HDL (show HSD11B1 Antibodies) in normal mice but also with the pathologically increased lipoprotein fraction in genetically modified mice; decreased apoM levels in apoA-I (show APOA1 Antibodies)-deficient mice suggest a connection between apoM and apoA-I (show APOA1 Antibodies) metabolism.
ApoM transcripts were detectable in mouse embryos from day 7.5 to day 18.5
The protein encoded by this gene is an apolipoprotein and member of the lipocalin protein family. It is found associated with high density lipoproteins and to a lesser extent with low density lipoproteins and triglyceride-rich lipoproteins. The encoded protein is secreted through the plasma membrane but remains membrane-bound, where it is involved in lipid transport. Alternate splicing results in both coding and non-coding variants of this gene.
, NG20-like protein
, alternative name: G3a, NG20
, protein G3a
, protein Px